StonvexLoading…
StonvexStonvexStonvexCore line items from KAVL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Annual 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $92.94K | $484.66K | $392.07K | $249.65K |
Operating Income | $-620.79K | $-16.65M | $-6.64M | $-6.08M |
Net Income | $-620.79K | $-16.63M | $-6.62M | $-6.06M |
EPS (Diluted) | $-0.05 | $-1.51 | $-0.61 | $-0.58 |
Total Assets | $931.43K | $669.26K | $11.50M | $12.23M |
Total Liabilities | $434.36K | $569.29K | $1.42M | $1.59M |
Cash & Equivalents | $0.00 | $0.00 | $0.00 | $0.00 |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 13.54M | 11.59M | 11.54M | 11.54M |